It is well-known that pro-inflammatory cytokines, particularly IL-1β, IL-6 or TNF-α, promote ovarian tumor growth and metastasis, and their high serum levels are correlated with poor clinical outcomes [71,72]. This evidence concerns the gene IL6 and ovarian neoplasm.